Assistant Professor | NYU Langone Health | United States
Dr. Ammar Javed is a distinguished researcher specializing in hepatobiliary and pancreatic surgery, with a robust background in both clinical and translational research. His work spans surgical outcomes, pancreatic cancer, and innovative perioperative care strategies, demonstrating a strong commitment to improving patient-centered treatments. Throughout his career, he has contributed extensively to high-impact journals, reflecting a focus on integrating molecular insights with practical surgical applications. His collaborative approach has fostered interdisciplinary research across leading institutions, enhancing both the scope and applicability of his findings. Dr. Javed’s publications reveal a deep engagement with emerging surgical innovations, neoadjuvant therapies, and post-operative management, positioning him as a leader in his field. His research has been recognized for its rigor, influence, and translational relevance, as evidenced by measurable impact on scholarly metrics. Scopus data indicate 8,312 citations, 195 documents, and an h-index of 37.
Profiles: Google Scholar | Scopus | ORCID
Featured Publications
1. Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., … (2018). Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, 359(6378), 926–930.
2. Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., … (2018). Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery, 8(9), 1112–1129.
3. Cohen, J. D., Javed, A. A., Thoburn, C., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., … (2017). Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proceedings of the National Academy of Sciences, 114(38), 10202–10207.
4. Janssen, Q. P., Buettner, S., Suker, M., Beumer, B. R., Addeo, P., Bachellier, P., … (2019). Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis. JNCI: Journal of the National Cancer Institute, 111(8), 782–794.
5. Groot, V. P., Gemenetzis, G., Blair, A. B., Rivero-Soto, R. J., Yu, J., Javed, A. A., … (2019). Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Annals of Surgery, 269(6), 1154–1162.